Pathway Genomics logo

Pathway Genomics Corporation


Pathway Genomics Stock

Founded in 2008, Pathway Genomics with the aim of providing users with the most validated and personalized healthcare information. The company’s CLIA and CAP-accredited clinical laboratory provides physicians and their patients with actionable, precision healthcare information to help improve or maintain health and wellness. Its testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, and drug response for specific medications.

Management Team

Michael Nova, M.D. Chief Innovation Officer

Notable Investors

Funding Information